Terms: = Uterine cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Prognosis
4 results:
1. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
[TBL] [Abstract] [Full Text] [Related]
2. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract] [Full Text] [Related]
3. Stage IB carcinoma of the cervix, the Norwegian Radium hospital. II. Results when pelvic nodes are involved.
Martimbeau PW; Kjorstad KE; Iversen T
Obstet Gynecol; 1982 Aug; 60(2):215-8. PubMed ID: 7155484
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of persistent cancer cells in vaginal smears of patients with cervical carcinoma treated by radiotherapy.
Bonte J; Ide P
J Reprod Med; 1971 May; 6(5):226-8. PubMed ID: 5094735
[TBL] [Abstract] [Full Text] [Related]
